^
Association details:
| Biomarker: | MCL1 overexpression |
|---|---|
| Cancer: | Colorectal Cancer |
| Drug: | APG1244 (Bcl2 inhibitor, Bcl-xL inhibitor) |
| Drug Class: | MCL1 inhibitor |
| Direction: | Sensitive |
Evidence:
Source:
Title:
977 - Mcl-1 levels critically determines the sensitivities of human colon cancer cells to APG1244, a novel Bcl-2 and Bcl-XLinhibitor, that induces Bax- and caspase-8- dependent apoptosis
Published date:
03/10/2021
Excerpt:
The current study focuses on demonstrating the therapeutic efficacies of APG1244 against colorectal cancer and understanding the underlying mechanisms....High levels of Mcl-1 in these cell lines were significantly correlated to decreased sensitivity to APG1244. APG1244, when combined with a Mcl-1 inhibitor, synergistically decreased the survival and induced apoptosis of APG1244-insensitive cell lines with high levels of Mcl-1.
